53
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Understanding the mechanisms and drivers of antimicrobial resistance.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To combat the threat to human health and biosecurity from antimicrobial resistance, an understanding of its mechanisms and drivers is needed. Emergence of antimicrobial resistance in microorganisms is a natural phenomenon, yet antimicrobial resistance selection has been driven by antimicrobial exposure in health care, agriculture, and the environment. Onward transmission is affected by standards of infection control, sanitation, access to clean water, access to assured quality antimicrobials and diagnostics, travel, and migration. Strategies to reduce antimicrobial resistance by removing antimicrobial selective pressure alone rely upon resistance imparting a fitness cost, an effect not always apparent. Minimising resistance should therefore be considered comprehensively, by resistance mechanism, microorganism, antimicrobial drug, host, and context; parallel to new drug discovery, broad ranging, multidisciplinary research is needed across these five levels, interlinked across the health-care, agriculture, and environment sectors. Intelligent, integrated approaches, mindful of potential unintended results, are needed to ensure sustained, worldwide access to effective antimicrobials.

          Related collections

          Author and article information

          Journal
          Lancet
          Lancet (London, England)
          1474-547X
          0140-6736
          Jan 9 2016
          : 387
          : 10014
          Affiliations
          [1 ] National Institute of Health Research Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, and Department of Infectious Diseases, Imperial College London, London, UK. Electronic address: alison.holmes@imperial.ac.uk.
          [2 ] National Institute of Health Research Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance, and Department of Infectious Diseases, Imperial College London, London, UK.
          [3 ] Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Clinical Microbiology and Infection Control, University Hospital of North Norway, Norway; Department of Medical Biology, University of Tromsø, Tromsø, Norway.
          [4 ] Department of Bacteriology and Immunology, Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway.
          [5 ] Institute for Science, Ethics and Innovation (iSEI), University of Manchester, Manchester, UK.
          [6 ] Oxford Clinical Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.
          [7 ] Worldwide Antimalarial Resistance Network (WWARN), and Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
          [8 ] Antimicrobials Research Group, Institute for Microbiology and Infection, University of Birmingham, Birmingham, UK.
          Article
          S0140-6736(15)00473-0
          10.1016/S0140-6736(15)00473-0
          26603922
          2437ed06-7de9-4d7d-bba4-4b07a675f8bc
          Copyright © 2016 Elsevier Ltd. All rights reserved.
          History

          Comments

          Comment on this article